Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment

The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing.

source https://www.ndtv.com/business/biocon-subsidiary-biocon-biologics-received-nod-to-use-cytosorb-in-covid-19-coronavirus-treatment-2235772